S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
LON:INDV

Indivior (INDV) Share Forecast, Price & News

GBX 1,590
+115.00 (+7.80%)
(As of 06/5/2023 ET)
Compare
Today's Range
1,566.20
1,664.77
50-Day Range
1,369.60
1,590
52-Week Range
1,330
2,020
Volume
573,348 shs
Average Volume
417,479 shs
Market Capitalization
£2.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 2,350

Indivior MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
47.2% Upside
GBX 2,340 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.78mentions of Indivior in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
£2.10 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars


INDV stock logo

About Indivior (LON:INDV) Stock

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Receive INDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

INDV Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
INDV.L - Indivior PLC
U.S. Loses to China in Shocking WAR GAMES
=== BREAKING === U.S. Loses to China in Shocking WAR GAMES Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon. Get the name of the stock here >>>
Indivior Announces Q1 2023 Financial Results
FY 2022 Financial Results Announced
Indivior To Acquire Opiant Pharmaceuticals
Indivior Announces Q3 2022 Financial Results
See More Headlines

INDV Price History

Industry, Sector and Symbol

Industry
Drugs - Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
885
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 2,340
High Stock Price Forecast
GBX 2,350
Low Stock Price Forecast
GBX 2,330
Forecasted Upside/Downside
+47.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
£-50,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£947 million
Cash Flow
GBX 593.26 per share
Book Value
GBX 52 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.19 billion
Optionable
Not Optionable
Beta
-0.06

Key Executives

  • Mr. Mark Crossley
    CEO & Exec. Director
  • Mr. Ryan Preblick
    CFO & Exec. Director
  • Dr. Christian Heidbreder
    Chief Scientific Officer
  • Mr. Jason Thompson
    VP of Investor Relations
  • Ms. Cynthia Cetani
    Chief Integrity & Compliance Officer
  • Mr. Jeffrey W. Burris (Age 51)
    Chief Legal Officer
  • Mr. Jon Fogle
    Chief HR Officer
  • Mr. Richard Simkin
    Chief Commercial & Strategy Officer
  • Mr. Hillel West
    Chief Manufacturing & Supply Officer
  • Ms. Nina DeLorenzo
    Chief Global Impact Officer













INDV Stock - Frequently Asked Questions

Should I buy or sell Indivior stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INDV shares.
View INDV analyst ratings
or view top-rated stocks.

What is Indivior's stock price forecast for 2023?

2 Wall Street research analysts have issued twelve-month target prices for Indivior's stock. Their INDV share price forecasts range from GBX 2,330 to GBX 2,350. On average, they expect the company's share price to reach GBX 2,340 in the next twelve months. This suggests a possible upside of 47.2% from the stock's current price.
View analysts price targets for INDV
or view top-rated stocks among Wall Street analysts.

How have INDV shares performed in 2023?

Indivior's stock was trading at GBX 1,852 at the start of the year. Since then, INDV stock has decreased by 14.1% and is now trading at GBX 1,590.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Indivior own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Bigblu Broadband (BBB), Futura Medical (FUM), Directa Plus (DCTA), Lakehouse (LAKE), Aquila Services Group (AQSG), Benchmark (BMK), Bodycote (BOY), CityFibre Infrastructure (CITY), Deltex Medical Group (DEMG) and Kingfisher (KGF).

What is Indivior's stock symbol?

Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV."

How do I buy shares of Indivior?

Shares of INDV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Indivior's stock price today?

One share of INDV stock can currently be purchased for approximately GBX 1,590.

How much money does Indivior make?

Indivior (LON:INDV) has a market capitalization of £2.19 billion and generates £947 million in revenue each year. The specialty pharmaceutical company earns £-50,000,000.00 in net income (profit) each year or GBX (0.28) on an earnings per share basis.

How many employees does Indivior have?

The company employs 885 workers across the globe.

How can I contact Indivior?

Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The official website for the company is indivior.com. The specialty pharmaceutical company can be reached via phone at +44-1753-217800.

This page (LON:INDV) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -